55
Views
8
CrossRef citations to date
0
Altmetric
Original Research

Southern Saskatchewan Ticagrelor Registry experience

, , , , , , , , & show all
Pages 1427-1435 | Published online: 16 Oct 2014

References

  • WallentinLBeckerRCBudajAPLATO InvestigatorsTicagrelor versus clopidogrel in patients with acute coronary syndromesN Engl J Med2009361111045105719717846
  • BellADRoussinACartierRCanadian Cardiovascular SocietyThe use of antiplatelet therapy in the outpatient setting: Canadian Cardiovascular Society guidelinesCan J Cardiol201127Suppl AS1S5921640290
  • HammCWBassandJPAgewallSESC Committee for Practice GuidelinesESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: The Task Force for the management of acute coronary syndromes (ACS) in patients presenting without persistent ST-segment elevation of the European Society of Cardiology (ESC)Eur Heart J201132232999305421873419
  • StegPGJamesSKAtarDTask Force on the management of ST-segment elevation acute myocardial infarction of the European Society of Cardiology (ESC)ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevationEur Heart J201233202569261922922416
  • JneidHAndersonJLWrightRS2012 Writing Committee MembersAmerican College of Cardiology FoundationAmerican Heart Association Task Force on Practice Guidelines2012 ACCF/AHA focused update of the guideline for the management of patients with unstable angina/Non-ST-elevation myocardial infarction (updating the 2007 guideline and replacing the 2011 focused update): a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelinesCirculation2012126787591022800849
  • O’GaraPTKushnerFGAscheimDDAmerican College of Emergency Physicians; Society for Cardiovascular Angiography and Interventions2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice GuidelinesJ Am Coll Cardiol2013614e78e14023256914
  • GoodmanSGHuangWYanATExpanded Global Registry of Acute Coronary Events (GRACE2) InvestigatorsThe expanded Global Registry of Acute Coronary Events: baseline characteristics, management practices, and hospital outcomes of patients with acute coronary syndromesAm Heart J2009158219320119619694
  • AckmanMLGrahamMMHuiCTsuyukiRTEffect of a prior authorization process on antiplatelet therapy and outcomes in patients prescribed clopidogrel following coronary stentingCan J Cardiol200622141205120817151769
  • SheehyOLeLorierJRinfretSRestrictive access to clopidogrel and mortality following coronary stent implantationCMAJ2008178441342018268267
  • JackeviciusCALiPTuJVPrevalence, predictors, and outcomes of primary nonadherence after acute myocardial infarctionCirculation200811781028103618299512
  • YancyCWFowlerMBColucciWSUS Carvedilol Heart Failure Study GroupRace and the response to adrenergic blockade with carvedilol in patients with chronic heart failureN Engl J Med2001344181358136511333992
  • ThygesenKAlpertJSWhiteHDJoint ESC/ACCF/AHA/WHF Task Force for the Redefinition of Myocardial InfarctionUniversal definition of myocardial infarctionJ Am Coll Cardiol200750222173219518036459
  • CutlipDEWindeckerSMehranRAcademic Research ConsortiumClinical end points in coronary stent trials: a case for standardized definitionsCirculation2007115172344235117470709
  • MontalescotGLassenJFHammCWAmbulance or in-catheterization laboratory administration of ticagrelor for primary percutaneous coronary intervention for ST-segment elevation myocardial infarction: rationale and design of the randomized, double-blind Administration of Ticagrelor in the cath Lab or in the Ambulance for New ST elevation myocardial Infarction to open the Coronary artery (ATLANTIC) studyAm Heart J2013165451552223537967
  • CannonCPHarringtonRAJamesSPLATelet inhibition and patient Outcomes InvestigatorsComparison of ticagrelor with clopidogrel in patients with a planned invasive strategy for acute coronary syndromes (PLATO): a randomised double-blind studyLancet2010375971128329320079528
  • StoreyRFBeckerRCHarringtonRACharacterization of dyspnoea in PLATO study patients treated with ticagrelor or clopidogrel and its association with clinical outcomesEur Heart J201132232945295321804104
  • JamesSBudajAAylwardPTicagrelor versus clopidogrel in acute coronary syndromes in relation to renal function: results from the Platelet Inhibition and Patient Outcomes (PLATO) trialCirculation2010122111056106720805430
  • JamesSAngiolilloDJCornelJHPLATO Study GroupTicagrelor vs clopidogrel in patients with acute coronary syndromes and diabetes: a substudy from the PLATelet inhibition and patient Outcomes (PLATO) trialEur Heart J201031243006301620802246
  • HustedSJamesSBeckerRCPLATO study groupTicagrelor versus clopidogrel in elderly patients with acute coronary syndromes: a substudy from the prospective randomized PLATelet inhibition and patient Outcomes (PLATO) trialCirc Cardiovasc Qual Outcomes20125568068822991347
  • JamesSKStoreyRFKhurmiNSPLATO Study GroupTicagrelor versus clopidogrel in patients with acute coronary syndromes and a history of stroke or transient ischemic attackCirculation2012125232914292122572911
  • HeldCAsenbladNBassandJPTicagrelor versus clopidogrel in patients with acute coronary syndromes undergoing coronary artery bypass surgery: results from the PLATO (Platelet Inhibition and Patient Outcomes) trialJ Am Coll Cardiol201157667268421194870
  • WallentinLJamesSStoreyRFPLATO investigatorsEffect of CYP2C19 and ABCB1 single nucleotide polymorphisms on outcomes of treatment with ticagrelor versus clopidogrel for acute coronary syndromes: a genetic substudy of the PLATO trialLancet201037697491320132820801498
  • KohliPWallentinLReyesEReduction in first and recurrent cardiovascular events with ticagrelor compared with clopidogrel in the PLATO StudyCirculation2013127667368023277305
  • NikolicEJanzonMHauchOWallentinLHenrikssonMPLATO Health Economic Substudy GroupCost-effectiveness of treating acute coronary syndrome patients with ticagrelor for 12 months: results from the PLATO studyEur Heart J201334322022822719022
  • AlexopoulosDGoudevenosJAXanthopoulouIGRAPE InvestigatorsImplementation of contemporary oral antiplatelet treatment guidelines in patients with acute coronary syndrome undergoing percutaneous coronary intervention: a report from the GReek AntiPlatelet rEgistry (GRAPE)Int J Cardiol201316865329533523978364
  • GoudevenosJNtalasIXanthopoulouIKalantziKPipilisAAlexopoulosDUse of ticagrelor in patients with ST-elevation myocardial infarction undergoing thrombolysisJ Thromb Thrombolysis201437335635723860883
  • KivimäkiMBattyGDHamerMInfluence of retirement on nonadherence to medication for hypertension and diabetesCMAJ201318517E784E79024082018
  • AlexanderKPNewbyLKArmstrongPWAmerican Heart Association Council on Clinical CardiologySociety of Geriatric CardiologyAcute coronary care in the elderly, part II: ST-segment-elevation myocardial infarction: a scientific statement for healthcare professionals from the American Heart Association Council on Clinical Cardiology: in collaboration with the Society of Geriatric CardiologyCirculation2007115192570258917502591
  • AlexanderKPNewbyLKCannonCPAmerican Heart Association Council on Clinical CardiologySociety of Geriatric CardiologyAcute coronary care in the elderly, part I: Non-ST-segment-elevation acute coronary syndromes: a scientific statement for healthcare professionals from the American Heart Association Council on Clinical Cardiology: in collaboration with the Society of Geriatric CardiologyCirculation2007115192549256917502590
  • AlexanderKPRoeMTChenAYCRUSADE InvestigatorsEvolution in cardiovascular care for elderly patients with non-ST-segment elevation acute coronary syndromes: results from the CRUSADE National Quality Improvement InitiativeJ Am Coll Cardiol20054681479148716226171
  • GurbelPABlidenKPButlerKRandomized double-blind assessment of the ONSET and OFFSET of the antiplatelet effects of ticagrelor versus clopidogrel in patients with stable coronary artery disease: the ONSET/OFFSET studyCirculation2009120252577258519923168
  • SciricaBMCannonCPEmanuelssonHPLATO InvestigatorsThe incidence of bradyarrhythmias and clinical bradyarrhythmic events in patients with acute coronary syndromes treated with ticagrelor or clopidogrel in the PLATO (Platelet Inhibition and Patient Outcomes) trial: results of the continuous electrocardiographic assessment substudyJ Am Coll Cardiol201157191908191621545948
  • CairnsJAMcMurtryMSOral antithrombotic therapy in atrial fibrillation associated with acute or chronic coronary artery diseaseCan J Cardiol2013297(Suppl)S60S7023790600
  • RodriguezFCannonCPStegPGREACH Registry InvestigatorsPredictors of long-term adherence to evidence-based cardiovascular disease medications in outpatients with stable atherothrombotic disease: findings from the REACH RegistryClin Cardiol2013361272172724166484
  • GoudevenosJNtalasIXanthopoulouIKalantziKPipilisAAlexopoulosDUse of ticagrelor in patients with ST-elevation myocardial infarction undergoing thrombolysisJ Thromb Thrombolysis201437335635723860883